 |
 |
 |
||
|
||||
 |
|
| Updated Sep. 9, 2010 |
|
||||||||
 |
|
 |
|
 |
|
 |
|
 |
|
||||||||
|
|
| Swallowing the Wrong Pill
Criminal Drug Diversion by Medical Professionals: A Federal Prosecutor’s Perspective GUEST EDITORIAL | ISSUE: MAY, 2009 During the past two years, federal prosecutor Ronald J. Friedman has participated in a series of prosecutions of physicians and other health care professionals for criminal conduct involving the unlawful diversion of controlled substances. |
|
| Retaining Legal Counsel: An Attorney’s Perspective
POLICY & MANAGEMENT | ISSUE: JUNE, 2007 Consultation with a lawyer is probably necessary if a physician receives a notice of inspection from a state medical board or the Drug Enforcement Agency, or if changes have been made in law or policy that affect daily practice. |
|
| The Implications of the FDA Warning on Methadone
POLICY & MANAGEMENT | ISSUE: FEBRUARY, 2007 Recent government warnings suggest need for adjustments to informed consent process and additional patient education. |
|
| The DEA’s Final Policy Statement and Practitioner’s Manual
POLICY & MANAGEMENT | ISSUE: DECEMBER, 2006 On September 6, 2006, the Drug Enforcement Administration (DEA) released several items related to the use of controlled substances for pain. A summary of these items is provided in this article. |
|
| A Letter to Your Patients
POLICY & MANAGEMENT | ISSUE: AUGUST, 2006 Why doctors sometimes say "no" and sometimes "yes" to the use of controlled substances to treat pain. |
|
| Discharging Patients Who Abuse Controlled Substances
POLICY & MANAGEMENT | ISSUE: APRIL, 2006 Successful physician–patient relationships are based on mutual accountability and trust. When a patient using controlled substances for pain breaches the physician's trust, the physician must decide whether to continue treating the patient using drug or nondrug modalities or to discharge the patient. |
|
| Discontinuing Palladone: A Legal/Regulatory Perspective
POLICY & MANAGEMENT | ISSUE: OCTOBER, 2005 On July 13, 2005, the Food and Drug Administration (FDA) announced that Purdue Pharma had elected to pull its 24-hour–acting opioid drug Palladone (hydromorphone extended-release) from the market. The FDA and others have been concerned about the interaction of Palladone and alcohol. |
|
| A Treatment Agreement Establishes Boundaries With Patients
Back to Basics Part II POLICY & MANAGEMENT | ISSUE: AUGUST, 2005 I often get asked the following question: Should I use a treatment agreement (TA) (sometimes referred to as a "narcotic contract," "controlled substances agreements" or "pain medication agreement") with my patients prior to treating pain with opioids? My answer always is: "It depends on the patient and the nature of your practice, not to mention your state's position on the matter." |
|
| Informed Consent Facilitates Use of Controlled Substances
POLICY & MANAGEMENT | ISSUE: APRIL, 2005 The legal concept of "informed consent" traces back to the tort of battery--liability for the nonconsensual touching of another. Today, most legal challenges involving "informed consent" concern the issue of whether the provider gave the patient sufficient information about the subject treatment to make a decision about his or her healthcare options and risks to his or her body. |
|
| Legal Expert Reviews the DEA's Interim Policy on Prescribing
POLICY & MANAGEMENT | ISSUE: DECEMBER, 2004 On November 12, 2004, the U.S. Drug Enforcement Administration (DEA) published an "Interim Policy Statement" (Interim Policy) in the Federal Register relating to a document that the DEA drafted, published and then retracted, called "Prescription Pain Medications: Frequently Asked Questions and Answers" (the FAQ). |
|
| Do Your Paperwork When Prescribing Controlled Substances
POLICY & MANAGEMENT | ISSUE: JUNE, 2004 Many U.S. state medical boards proclaim that physicians "should not fear disciplinary action from the board or other state regulatory or enforcement agency for prescribing, dispensing or administering controlled substances, including opioid analgesics, for a legitimate medical purpose and in the usual course of professional practice." |
| |
| MOREPAIN & THE LAW | |
| |
| No more articles availalble | |
 Pain & The Law Archives |
| home | about us | advertise | contact | publications |